CMC and Technology Transfer
CMC and tech transfer consulting for biotech and medical device teams.
Moving a process into a CDMO, scaling a drug product, or locking in a fill-finish supplier is where timelines slip quietly. The science is usually sound. The handoffs are where programs lose months.
NanoCoeur has done this work from the inside: CDMO technology transfer for a BARDA-funded Class III medical device, drug product CDMO work for a sterile, IV-administered product including fill-finish, and the supply agreements that sit behind both. We run the transfer as a program, with one schedule, clear owners, and acceptance criteria both sides agreed to before the first batch.
Where we help
- Tech transfer planning: transfer scope, documentation package, acceptance criteria, and a schedule the sponsor and the CDMO both commit to.
- CDMO and supplier oversight: a governance cadence that reviews the vendor's own trend data, not only the monthly slide deck.
- Drug product and fill-finish: supply and OEM agreements, slot planning, and readiness for sterile fill-finish runs.
- Scale-up and capital projects: equipment, facility, and capacity projects tied to the clinical and commercial timeline.
- CMC in the regulatory plan: CMC deliverables kept in sync with IND and later-stage filing milestones.
Who this is for
Biotech and device teams moving to a CDMO for the first time, changing CDMOs, or scaling for later-stage clinical supply, without a full-time CMC program lead.